Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
PLoS Genet ; 17(5): e1009587, 2021 05.
Article in English | MEDLINE | ID: mdl-34033652

ABSTRACT

Human pluripotent stem cells (PSCs) express human endogenous retrovirus type-H (HERV-H), which exists as more than a thousand copies on the human genome and frequently produces chimeric transcripts as long-non-coding RNAs (lncRNAs) fused with downstream neighbor genes. Previous studies showed that HERV-H expression is required for the maintenance of PSC identity, and aberrant HERV-H expression attenuates neural differentiation potentials, however, little is known about the actual of function of HERV-H. In this study, we focused on ESRG, which is known as a PSC-related HERV-H-driven lncRNA. The global transcriptome data of various tissues and cell lines and quantitative expression analysis of PSCs showed that ESRG expression is much higher than other HERV-Hs and tightly silenced after differentiation. However, the loss of function by the complete excision of the entire ESRG gene body using a CRISPR/Cas9 platform revealed that ESRG is dispensable for the maintenance of the primed and naïve pluripotent states. The loss of ESRG hardly affected the global gene expression of PSCs or the differentiation potential toward trilineage. Differentiated cells derived from ESRG-deficient PSCs retained the potential to be reprogrammed into induced PSCs (iPSCs) by the forced expression of OCT3/4, SOX2, and KLF4. In conclusion, ESRG is dispensable for the maintenance and recapturing of human pluripotency.


Subject(s)
Pluripotent Stem Cells/metabolism , RNA, Long Noncoding/genetics , Cell Differentiation/genetics , Cells, Cultured , Cellular Reprogramming , Female , Gene Silencing , Humans , Kruppel-Like Factor 4 , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Pluripotent Stem Cells/cytology
2.
Nat Methods ; 15(9): 732-740, 2018 09.
Article in English | MEDLINE | ID: mdl-30127506

ABSTRACT

Human embryonic stem cells (hESCs) can be captured in a primed state in which they resemble the postimplantation epiblast, or in a naive state where they resemble the preimplantation epiblast. Naive-cell-specific culture conditions allow the study of preimplantation development ex vivo but reportedly lead to chromosomal abnormalities, which compromises their utility in research and potential therapeutic applications. Although MEK inhibition is essential for the naive state, here we show that reduced MEK inhibition facilitated the establishment and maintenance of naive hESCs that retained naive-cell-specific features, including global DNA hypomethylation, HERVK expression, and two active X chromosomes. We further show that hESCs cultured under these modified conditions proliferated more rapidly; accrued fewer chromosomal abnormalities; and displayed changes in the phosphorylation levels of MAPK components, regulators of DNA damage/repair, and cell cycle. We thus provide a simple modification to current methods that can enable robust growth and reduced genomic instability in naive hESCs.


Subject(s)
Embryonic Stem Cells/metabolism , Genomic Instability , MAP Kinase Kinase Kinases/antagonists & inhibitors , Protein Kinase Inhibitors/pharmacology , DNA Methylation , Embryonic Stem Cells/enzymology , Humans , Proteome , Transcriptome
3.
J Pharmacol Sci ; 133(1): 57-60, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28081948

ABSTRACT

Given that Cav3.2 T-type Ca2+ channels were functionally regulated by asparagine (N)-linked glycosylation, we examined effects of high glucose on the function of Cav3.2, known to regulate secretory function, in neuroendocrine-like differentiated prostate cancer LNCaP cells. High glucose accelerated the increased channel function and overexpression of Cav3.2 during neuroendocrine differentiation, the former prevented by enzymatic inhibition of N-glycosylation and cleavage of N-glycans. Hyperglycemia thus appears to induce N-linked glycosylation-mediated functional upregulation and overexpression of Cav3.2 in neuroendocrine-like differentiated prostate cancer cells.


Subject(s)
Calcium Channels, T-Type/biosynthesis , Cell Differentiation , Gene Expression Regulation, Neoplastic , Glucose/pharmacology , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/pathology , Up-Regulation/drug effects , 1-Methyl-3-isobutylxanthine/pharmacology , Bucladesine/pharmacology , Cell Line, Tumor , Glycosylation/drug effects , Humans , Male , Membrane Potentials/drug effects , Tunicamycin/pharmacology
4.
Article in English | MEDLINE | ID: mdl-17554179

ABSTRACT

Axin is a negative regulator of the canonical Wnt signalling pathway that mediates the phosphorylation of beta-catenin by glycogen synthase kinase 3beta. The DIX domain of rat axin, which is important for its homooligomerization and interactions with other regulators in the Wnt pathway, was purified and crystallized by the sitting-drop vapour-diffusion technique using polyethylene glycol 6000 and lithium sulfate as crystallization agents. Crystals belong to space group P6(1) or P6(5), with unit-cell parameters a = b = 91.49, c = 84.92 A. An X-ray diffraction data set has been collected to a nominal resolution of 2.9 A.


Subject(s)
Intracellular Signaling Peptides and Proteins/chemistry , Microfilament Proteins/chemistry , Repressor Proteins/chemistry , Animals , Axin Protein , Crystallization , Crystallography, X-Ray , Intracellular Signaling Peptides and Proteins/metabolism , Microfilament Proteins/metabolism , Protein Structure, Tertiary , Rats , Repressor Proteins/physiology , Signal Transduction/physiology , Wnt Proteins/chemistry , Wnt Proteins/physiology
5.
Biochem Pharmacol ; 97(3): 300-9, 2015 Oct 01.
Article in English | MEDLINE | ID: mdl-26256074

ABSTRACT

Neuroendocrine-differentiated prostate cancer cells may contribute to androgen-independent proliferation of surrounding cells through Ca(2+)-dependent secretion of mitogenic factors. Human prostate cancer LNCaP cells, when neuroendocrine-differentiated, overexpress Cav3.2 T-type Ca(2+) channels that contribute to Ca(2+)-dependent secretion. Given evidence for the acceleration of Cav3.2 activity by hydrogen sulfide (H2S), we examined the roles of the H2S/Cav3.2 pathway and then analyzed the molecular mechanisms of the Cav3.2 overexpression in neuroendocrine-differentiated LNCaP cells. LNCaP cells were differentiated by dibutyryl cyclic AMP. Protein levels and T-type Ca(2+) channel-dependent currents (T-currents) were measured by immunoblotting and whole-cell pacth-clamp technique, respectively. Spontaneous release of prostatic acid phosphatase (PAP) was monitored to evaluate secretory function. The differentiated LNCaP cells exhibited neurite outgrowth, androgen-independent proliferation and upregulation of mitogenic factors, and also showed elevation of Cav3.2 expression or T-currents. Expression of cystathionine-γ-lyase (CSE) and cystathionine-ß-synthase (CBS), H2S-forming enzymes, and spontaneous secretion of PAP increased following the differentiation. The augmented T-currents were enhanced by H2S donors and suppressed by inhibitors of CSE, but not CBS. The PAP secretion was reduced by inhibition of CSE or T-type Ca(2+) channels. During differentiation, Egr-1 and REST, positive and negative transcriptional regulators for Cav3.2, were upregulated and downregulated, respectively, and Egr-1 knockdown prevented the Cav3.2 overexpression. Our data suggest that, in neuroendocrine-differentiated LNCaP cells, H2S formed by the upregulated CSE promotes the activity of the upregulated Cav3.2, leading to the elevated secretory functions. The overexpression of Cav3.2 appears to involve upregulation of Egr-1 and downregulation of REST.


Subject(s)
Calcium Channels, T-Type/biosynthesis , Cell Differentiation/drug effects , Hydrogen Sulfide/pharmacology , Neuroendocrine Cells/drug effects , Prostatic Neoplasms/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Early Growth Response Protein 1/metabolism , Humans , Hydrogen Sulfide/metabolism , Male , Neuroendocrine Cells/metabolism , Neuroendocrine Cells/pathology , Neurotensin/metabolism , Parathyroid Hormone-Related Protein/metabolism , Prostatic Neoplasms/pathology , Repressor Proteins/metabolism , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL